Literature DB >> 30317183

Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes.

Ankur Guliani1, Anuradha Bishnoi1, Divya Aggarwal2, Davinder Parsad3.   

Abstract

Entities:  

Keywords:  blisters; bullous pemphigoid; diabetic male; teneligliptin

Mesh：

Substances：

Year:  2018        PMID： 30317183     DOI： 10.1136/postgradmedj-2018-136044

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  3 in total

1.  Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan.

Authors:  Takashi Kadowaki; Masakazu Haneda; Hiroshi Ito; Kazuyo Sasaki; Miyuki Matsukawa; Yuka Yamada
Journal:  Adv Ther       Date:  2019-12-23       Impact factor: 3.845

2.  Linagliptin-Associated Alopecia and Bullous Pemphigoid.

Authors:  Ali Someili; Khalid Azzam; Mohannad Abu Hilal
Journal:  Eur J Case Rep Intern Med       Date:  2019-09-10

Review 3.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.